Next Quarterly Earnings
No earnings planned
Currently, no future quarterly earnings are announced for this company.Avidity Biosciences is a biotechnology company developing novel antibody-oligonucleotide conjugates (AOCs). The company focuses on the discovery and development of innovative medicines for rare and severe diseases, particularly muscle disorders. Avidity aims to improve therapeutic options for patients with its advanced platform.
Avidity Biosciences last reported quarterly earnings on 11/11/2025 (Q3 2025).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.